Smith & Nephew plc (ADR)  

(Public, NYSE:SNN)   Watch this stock  
Find more results for SNN
31.17
+0.62 (2.03%)
Feb 12 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 30.80 - 31.18
52 week 30.23 - 37.84
Open 30.93
Vol / Avg. 559,462.00/428,823.00
Mkt cap 13.54B
P/E 34.09
Div/yield 0.38/1.98
EPS 0.91
Shares 894.45M
Beta 0.84
Inst. own 3%
May 5, 2016
Q1 2016 Smith & Nephew PLC Trading Statement Release Add to calendar
Apr 14, 2016
Smith & Nephew PLC Annual Shareholders Meeting Add to calendar
Apr 8, 2016
Smith & Nephew PLC Annual Shareholders Meeting (Estimated) - 9:00AM EDT - Add to calendar
Feb 4, 2016
Q4 2015 Smith & Nephew PLC Earnings Call - Webcast
Feb 4, 2016
Q4 2015 Smith & Nephew PLC Earnings Release
Nov 18, 2015
Smith & Nephew PLC at Jefferies Autumn Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 4.87% 8.85%
Operating margin 8.00% 13.51%
EBITD margin - 30.34%
Return on average assets 3.19% 5.67%
Return on average equity 5.72% 10.24%
Employees 14,000 -
CDP Score - 95 B

Address

15 Adam Street
LONDON, WC2N 6LA
United Kingdom - Map
+44-20-74017646 (Phone)
+44-20-79303353 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices, which includes orthopedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Company's Advanced Surgical Devices (ASD) segment offers products and technologies, which include orthopedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other advanced surgical devices (ASD). The Company's Advanced Wound Management (AWM) segment offers products, including Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 100 countries.

Officers and directors

Olivier Bohuon Chief Executive Officer, Executive Director
Age: 56
Bio & Compensation  - Reuters
Julie Brown Chief Financial Officer, Executive Director
Age: 52
Bio & Compensation  - Reuters
Rodrigo Bianchi President, IRAMEA
Age: 55
Bio & Compensation  - Reuters
Michael G. Frazzette President - Advanced Surgical Devices
Age: 53
Bio & Compensation  - Reuters
R. Gordon Howe President - Global Operations
Age: 52
Bio & Compensation  - Reuters
Diogo Moreira-Rato President - Europe and Canada
Age: 53
Bio & Compensation  - Reuters
Glenn S. Warner President - Advanced Wound Management
Age: 52
Bio & Compensation  - Reuters
John W. Campo Chief Legal Officer
Age: 60
Bio & Compensation  - Reuters
Helen Maye Chief Human Resources Officer
Age: 55
Bio & Compensation  - Reuters
Cyrille Petit Chief Corporate Development Officer
Age: 44
Bio & Compensation  - Reuters